Summary:
Blood Sample for Crohns Disease or Ulcerative Colitis (UC)
The PRECIOUS Study: Predicting Crohn’s & Colitis Outcomes in the United States
If you are between the ages of 16-80 and suffer from Crohn’s disease or ulcerative colitis (UC), you may be eligible to participate in this research study.
Who can participate?
- The target patient population is newly diagnosed, treatment naive patients with active Crohn’s disease or UC
- Not currently on steroids, and at least 7 days since last steroid use
- Experiencing a flare or period of active disease
- Not scheduled to start biologics as first line therapy
Qualified Participants May Receive:
What are the benefits?
If the study is successful, it will provide further evidence for the use of the test to drive treatment decisions in IBD and will be the first step towards personalized medicine in the US. We will reimburse any reasonable travel and parking costs up to a value of $50.